MASAC Recommendations on Standardized Testing and Surveillance for Inhibitors in Patients with Hemophilia A & B
The following document was approved by the Medical and Scientific Advisory Council (MASAC) on August 15, 2015, and adopted by the NHF Board of Directors on October 6, 2015. Inhibitors are an important public health issue that result in increased morbidity and mortality and substantially increased financial